World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 14 June 2021
Main ID:  NCT04914208
Date of registration: 30/05/2021
Prospective Registration: Yes
Primary sponsor: University of Göttingen
Public title: Effect of Wearing Face Masks on Salivary Parameters and Halitosis
Scientific title: Effect of Wearing Face Masks on Oral Health
Date of first enrolment: July 1, 2021
Target sample size: 40
Recruitment status: Not yet recruiting
URL:  https://clinicaltrials.gov/show/NCT04914208
Study type:  Interventional
Study design:  Allocation: Randomized. Intervention model: Crossover Assignment. Primary purpose: Prevention. Masking: None (Open Label).  
Phase:  N/A
Countries of recruitment
Germany
Contacts
Name:     Annette Wiegand, Prof. Dr. med. dent.
Address: 
Telephone: 01149-55139
Email: annette.wiegand@med.uni-goettingen.de
Affiliation: 
Key inclusion & exclusion criteria

Inclusion Criteria:

- Oral healthy adult volunteers who are able to give written consent

Exclusion Criteria:

- Non-fulfillment of the inclusion criteria

- Denied access to the University Medical Center Goettingen at the Corona screening

- Exemption from wearing a face mask for medical reasons

- Medical reasons hindering participants from refraining eating and drinking prior
(except for water) or during the visits

- Hyposalivation / xerostomia (unstimulated saliva < 0.3 mL/min, stimulated saliva < 0.7
mL/min)

- Refusal to use fluoridated toothpastes

- Smoking



Age minimum: 18 Years
Age maximum: N/A
Gender: All
Health Condition(s) or Problem(s) studied
Dry Mouth
Halitosis
Intervention(s)
Device: DIY face mask
Device: FFP2 respirator mask
Device: Surgical face mask
Other: Use of fluoridated toothpaste
Other: Waiting for 4 hours without wearing a mask
Primary Outcome(s)
Determination of unstimulated saliva flow rate [Time Frame: Each day, prior (between 8 and 9 a.m.) and after wearing a face mask for 4 hours or 4 hours without wearing any mask. Saliva samples are collected for 5 min each.]
Secondary Outcome(s)
Determination of stimulated saliva flow rate [Time Frame: Each day, prior (between 8 and 9 a.m.) and after wearing a face mask for 4 hours or 4 hours without wearing any mask. Stimulated saliva samples are collected for 5 min while chewing a paraffin pellet.]
Determination of unstimulated and stimulated saliva pH [Time Frame: Each day, prior (between 8 and 9 a.m.) and after wearing a face mask for 4 hours or 4 hours without wearing any mask. Saliva samples are collected for 5 min each. Stimulated saliva samples are collected while chewing a paraffin pellet.]
Determination of unstimulated and stimulated salivary buffer capacity [Time Frame: Each day, prior (between 8 and 9 a.m.) and after wearing a face mask for 4 hours or 4 hours without wearing any mask. Saliva samples are collected for 5 min each. Stimulated saliva samples are collected while chewing a paraffin pellet.]
Determination of volatile sulphur compounds (VSC) [Time Frame: Each day, prior (between 8 and 9 a.m.) and after wearing a face mask for 4 hours or 4 hours without wearing any mask.]
Secondary ID(s)
2021-01521
30/2/21
FaceMasks-Halitosis
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history